Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy (Q43751488)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

ovarian carcinoma

1 reference

based on heuristic

inferred from title

Athanasios Dimopoulos

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Theodora Psaltopoulou

object named as

Theodora Psaltopoulou

2

0 references

Aristotle Bamias

1

object named as

Aristotle Bamias

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dimitrios Haidopoulos

4

object named as

Dimitrios Haidopoulos

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Evangelos Bournakis

6

object named as

Evangelos Bournakis

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Alexandros Rodolakis

8

object named as

Alexandros Rodolakis

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

9

object named as

George Vlahos

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Maria Sotiropoulou

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Evangelos Lianos

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Christos Papadimitriou

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

1 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

116

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1462-1468

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

21 January 2018

New therapy for ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal chemotherapy treatment for women with recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24915

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24915

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43751488&oldid=2103034485"